Orion Biotech Opportunities Operating Income

Orion Biotech Opportunities (ORIA) currently reports a operating income of $-900K as of December 2022. That compares with $-630K in the prior-year period — down 43.2% year over year. Use the charts on this page to explore Orion Biotech Opportunities's operating income history and peer comparisons.

Orion Biotech Opportunities's operating income decreased from $-630K to $-900K — a 43.2% year-over-year decrease (period ending December 2022). Watching multi-year history on the chart below helps separate one-off swings from a lasting trend.

Orion Biotech Opportunities reported $-900K in operating income as of December 2022. That compares with $-630K in the prior-year period — down 43.2% year over year. Absolute dollar amounts are most useful when compared with prior periods, peers, and related line items such as revenue, assets, or liabilities on Stockcircle.

Start with the current operating income of $-900K, then check the historical chart for trend and the peer comparison chart for relative positioning. From there, open related valuation or income-statement pages for Orion Biotech Opportunities, and consider following ORIA for alerts when major investors trade the stock.